Advisory meetings are subject to federal transparency requirements: experts with financial stakes may serve, but their relationships must be disclosed and the FDA is expected to explain why the panelist's expertise outweighs the conflict
However, the strength of effects, ideal dosing, and long-term outcomes are not fully established for general consumer use, and clinical standards vary by region
These five criteria separate them
The COA links directly from the product page to the Janoshik verification platform for independent verification of compound identity and purity
Single-vial format lets you test a compound without committing to a full sealed box, useful for short pilot protocols
They are not interchangeable, and the choice depends on symptoms, blood results, and clinical judgement